BOCA RATON, Fla., July 19 /PRNewswire-FirstCall/ -- Nabi Biopharmaceuticals will announce second quarter 2006 financial results on Wednesday, July 26, 2006, after market close. The company will host a conference call and live webcast at 4:30 p.m. ET.
The live webcast can be accessed at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=100445&eventID=1355022 or via the Nabi Biopharmaceuticals website at http://www.nabi.com . If you do not have Internet access, the U.S./Canada call-in number is 866-510-0705 conference code 52609710, and the international call-in number is 617-597-5363 conference code 52609710. An audio replay will be available for U.S./Canada callers at 888-286-8010 conference code 61198477, and for international callers at 617-801-6888 conference code 61198477.
An archived version of the webcast will be available at the same Internet address through August 2, 2006. The audio replay will also be available through August 2, 2006. The press release will be available on the company's website at http://www.nabi.com .
About Nabi Biopharmaceuticals
Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and market products that fight serious medical conditions. The company has three products on the market today: PhosLo(R) (calcium acetate), Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], and Aloprim(TM) (allopurinol sodium) for Injection. Nabi Biopharmaceuticals is focused on developing products that address unmet medical needs and offer commercial opportunities in our core business areas: Gram-positive bacterial infections, hepatitis and transplant, kidney disease (nephrology) and nicotine addiction. For a complete list of pipeline products, please go to: http://www.nabi.com/pipeline/index.php . The company is headquartered in Boca Raton, Florida. For additional information about Nabi Biopharmaceuticals, please visit our website: http://www.nabi.com .
Nabi BiopharmaceuticalsCONTACT: Thomas E. Rathjen, Vice President, Investor Relations, NabiBiopharmaceuticals, +1-561-989-5800
